1235313-67-3 Usage
Chemical structure
1-(4-methoxybenzyl)-5-isobutyl-1H-pyrazole-4-carboxylic acid is a chemical compound with a complex structure, consisting of a pyrazole ring with a carboxylic acid group attached.
Functional groups
The compound contains a methoxybenzyl group and an isobutyl group, which are both attached to the pyrazole ring.
Potential applications
1-(4-methoxybenzyl)-5-isobutyl-1H-pyrazole-4-carboxylic acid may have potential pharmaceutical or biological applications due to its unique structure and functional groups.
Drug development
It could potentially be used in drug development or research as a building block for more complex molecules.
Organic chemistry
The compound may have properties that make it useful in the field of organic chemistry for the synthesis of other compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 1235313-67-3 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,2,3,5,3,1 and 3 respectively; the second part has 2 digits, 6 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 1235313-67:
(9*1)+(8*2)+(7*3)+(6*5)+(5*3)+(4*1)+(3*3)+(2*6)+(1*7)=123
123 % 10 = 3
So 1235313-67-3 is a valid CAS Registry Number.
1235313-67-3Relevant academic research and scientific papers
NOVEL THIAZOLES DERIVATIVES AND THEIR USE AS POSITIVE ALLOSTERIC MODULATORS OF METABOTROPIC GLUTAMATE RECEPTORS
-
Page/Page column 41-42, (2010/08/04)
The present invention relates to novel compounds of Formula (I), wherein M, P, A and (B)n are defined as in Formula (I); invention compounds are modulators of metabotropic glutamate receptors - subtype 4 ( mGluR4 ) which are useful for the treatment or prevention of central nervous system disorders as well as other disorders modulated by mGluR4 receptors. The invention is also directed to pharmaceutical compositions and the use of such compounds in the manufacture of medicaments, as well as to the use of such compounds for the prevention and treatment of such diseases in which mGluR4 is involved.
